SkyePharma enhances liquidity with revised finance and timeshare manufacturing
This article was originally published in Scrip
Executive Summary
In a bid to enhance its anticipated short-term liquidity position, SkyePharma has entered into an amendment agreement in respect of its existing CRC Finance Facility. Separately, the company has also agreed a manufacturing alliance with the Aenova Group to increase usage of SkyePharma’s manufacturing facility in Saint Quentin-Fallavier, Lyon, France.